Related Experiment Video

Updated: May 11, 2026

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

Myocardial damage following cardiac surgery: comparison between single-dose Celsior cardioplegic solution and cold

P Giordano1, G Scrascia, D D'Agostino

  • 1Division of Cardiac Surgery, Department of Emergency and Organ Transplant, University of Bari "Aldo Moro", Bari, Italy.

Perfusion
|May 15, 2013
PubMed

Insights

Cold blood cardioplegia offers superior myocardial protection during heart valve surgery compared to the Celsior solution. This approach significantly reduces cardiac enzyme release, indicating less myocardial damage post-operation.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardioplegia

Background:

  • Myocardial protection is crucial during cardiac surgery.
  • Various cardioplegic solutions exist for protecting the heart muscle.

Purpose of the Study:

  • To compare myocardial damage between Celsior and cold blood cardioplegia.
  • To assess the efficacy of different cardioplegic strategies in heart valve surgery.

Main Methods:

  • A comparative study involving 32 patients undergoing heart valve surgery.
  • Patients were divided into two groups: Celsior (n=16) and cold blood cardioplegia (n=16).
  • Myocardial damage was assessed by measuring creatine kinase-MB (CK-MB) and cardiac troponin I (cTnI) levels post-operatively.

Main Results:

  • The Celsior group showed significantly higher CK-MB and cTnI levels post-surgery.
  • Peak cTnI levels were notably higher in the Celsior group (19.4 ± 13.4 ng/mL) versus the cold blood group (9.7 ± 7 ng/mL).
  • While not statistically significant (p=0.07), peak CK-MB levels were also higher in the Celsior group.

Conclusions:

  • Cold blood cardioplegia demonstrates a protective effect against perioperative myocardial damage.
  • Repeated cold blood cardioplegia is more effective than a single dose of Celsior in minimizing heart muscle injury during valve operations.

Keywords:
cardioplegic solutionischemia/reperfusionmyocardial protectionorgan preservationtroponin I

More Related Videos

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Pre-clinical Model of Cardiac Donation after Circulatory Death06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...